“Metabolizing systems” are responsible for the quick inactivation of noradrenaline released from adrenergic nerve endings: a transport mechanism (uptake1 or uptake2) is arranged in series with the intracellular enzyme (monoamine oxidase, MAO; catechol-O-methyltransferase, COMT). In the perfused rat heart, kenzyme-values were determined, i.e., those rate constants which characterize the unsaturated intracellular enzymes. In the extraneuronal metabolizing system kcomt > kmao for noradrenaline and adrenaline, while rather similar rate constants were obtained for dopamine. However, for the neuronal deaminating system, kmao is considerably higher than kmao for the extraneuronal system. Second, in the rat vas deferens it is demonstrated that inhibition of neuronal MAO leads to very pronounced rises of the axoplasmic noradrenaline concentration—and this is again a reflection of the high activity of neuronal MAO. In a third series of experiments (with the rat vas deferens), the evidence indicates that the neuronal inward transport of substrates of MAO fails to saturate the enzyme. This is the functional consequence of the high activity of neuronal MAO. It is concluded that a) neuronal MAO activity is very high, and—as a consequence—b) axoplasmic noradrenaline levels are very low.
Intracellular Enzyme Amine Concentration Neuronal Uptake Storage Vesicle Outward Transport
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Cassis L, Ludwig J, Grohmann M, Trendelenburg U (1986) The effect of partial inhibition of monoamine oxidase on the steady-state rate of deami-nation of 3H-catecholamines in two metabolizing systems. Naunyn-Schmiedeberg’s Arch Pharmacol 333: 253–261CrossRefGoogle Scholar
Graefe K-H, Stefano FJE, Langer SZ (1973) Preferential metabolism of (—)-3H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem Pharmacol 22: 1147–1160CrossRefGoogle Scholar
Grohmann M (1986) Neuronal and extraneuronal metabolism of different catecholamines (CA) in the perfused rat heart. Naunyn-Schmiedeberg’s Arch Pharmacol 332: R74CrossRefGoogle Scholar
Grohmann M, Henseling M, Cassis L, Trendelenburg U (1986) Errors introduced by a tritium label in position 8 of catecholamines. Naunyn-Schmiedeberg’s Arch Pharmacol 332: 34–42CrossRefGoogle Scholar
Iversen LL (1967) The uptake and storage of noradrenaline in sympathetic nerves. Cambridge University Press, CambridgeGoogle Scholar
Langeloh A (1986) The mechanism of action of indirectly acting sympathomimetic amines. Naunyn-Schmiedeberg’s Arch Pharmacol 332: R75Google Scholar
Leitz FH, Stefano FJE (1971) The effect of tyramine, amphetamine and meta-raminol on the metabolic disposition of 3H-norepinephrine released from the adrenergic neuron. J Pharmacol Exp Ther 178: 464–473PubMedGoogle Scholar
Sammet S, Graefe K-H (1979) Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: kinetic evidence for co-transport. Naunyn-Schmiedeberg’s Arch Pharmacol 309: 99–107CrossRefGoogle Scholar
Stute N, Trendelenburg U (1984) The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens. Naunyn-Schmiedeberg’s Arch Pharmacol 327: 124–132CrossRefGoogle Scholar
Trendelenburg U (1984) Metabolizing systems. In: Fleming WW, Langer SZ, Graefe K-H, Weiner N (eds) Neuronal and extraneuronal events in autonomic pharmacology. Raven Press, New York, pp 93–109Google Scholar
Trendelenburg U, Stefano FJE, Grohmann M (1983) The isotope effect of tritium in 3H-noradrenaline. Naunyn-Schmiedeberg’s Arch Pharmacol 323:128–140CrossRefGoogle Scholar